Helios Life Enterprises, Inc. (OTC: HLEN) is a biotechnology company focused on the prevention, treatment, and curing of age-related diseases. Operating as a science and technology holding company, it utilizes an AI-driven drug discovery platform to advance its pipeline of therapies. The company's core mission is to extend human healthspan by targeting fundamental aging processes like cellular senescence and mitochondrial dysfunction. Through its subsidiaries, Helios aims to translate scientific research into clinical applications for a healthier, longer life.

Founded in

United States